MENU
+Compare
LGND
Stock ticker: NASDAQ
AS OF
Dec 18, 03:35 PM (EDT)
Price
$119.82
Change
-$0.61 (-0.51%)
Capitalization
2.28B

LGND Ligand Pharmaceuticals Forecast, Technical & Fundamental Analysis

a biotechnology company

Industry Biotechnology
LGND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for LGND with price predictions
Dec 17, 2024

LGND in upward trend: price may jump up because it broke its lower Bollinger Band on December 12, 2024

LGND may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 38 cases where LGND's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 56 cases where LGND's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on December 17, 2024. You may want to consider a long position or call options on LGND as a result. In of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LGND advanced for three days, in of 328 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 214 cases where LGND Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for LGND turned negative on December 09, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LGND declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. LGND’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.705) is normal, around the industry mean (14.664). P/E Ratio (48.365) is within average values for comparable stocks, (87.689). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.783). LGND has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (14.493) is also within normal values, averaging (260.687).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
LGND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

LGND is expected to report earnings to fall 35.87% to $1.18 per share on February 06

Ligand Pharmaceuticals LGND Stock Earnings Reports
Q4'24
Est.
$1.18
Q3'24
Beat
by $0.50
Q2'24
Beat
by $0.34
Q1'24
Beat
by $0.36
Q4'23
Beat
by $0.39
The last earnings report on November 07 showed earnings per share of $1.84, beating the estimate of $1.34. With 23.55K shares outstanding, the current market capitalization sits at 2.28B.
A.I.Advisor
published Dividends

LGND paid dividends on July 01, 2010

Ligand Pharmaceuticals LGND Stock Dividends
А quarterly dividend of $0.12 per share was paid with a record date of July 01, 2010, and an ex-dividend date of July 02, 2010. Read more...
A.I. Advisor
published General Information

General Information

a biotechnology company

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
555 Heritage Drive
Phone
+1 858 550-7500
Employees
58
Web
https://www.ligand.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GRINX21.58N/A
N/A
Victory Diversified Stock R
RSMOX24.07N/A
N/A
Victory RS Mid Cap Growth A
FGROX29.03N/A
N/A
Emerald Growth Institutional
SASMX36.07-0.40
-1.10%
ClearBridge Small Cap Growth A
MFELX130.98-26.28
-16.71%
MFS Growth R1

LGND and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, LGND has been loosely correlated with DNLI. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if LGND jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LGND
1D Price
Change %
LGND100%
-1.56%
DNLI - LGND
53%
Loosely correlated
-0.30%
AXON - LGND
49%
Loosely correlated
-2.09%
VKTX - LGND
45%
Loosely correlated
-1.12%
JANX - LGND
41%
Loosely correlated
-3.17%
VCYT - LGND
41%
Loosely correlated
-2.52%
More